Ferran Nadeu

Grup de recerca

Patologia molecular en neoplàsies limfoides Post-doctoral researcher (R2A)

nadeu@recerca.clinic.cat 0000-0003-2910-9440

Segueix-lo/a a:

Publicacions destacades

Molecular map of chronic lymphocytic leukemia and its impact on outcome

Autors:
Knisbacher, Binyamin A; Lin, Ziao; Hahn, Cynthia K; Nadeu, Ferran; Duran-Ferrer, Marti;

(...)

Puente, Xose S; Stilgenbauer, Stephan; Wu, Catherine J; Campo, Elias; Getz, Gad.

Referència: Nature Genetics 2022.
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

Autors:
Nadeu, Ferran; Royo, Romina; Massoni-Badosa, Ramon; Garcia-Torre, Beatriz; Duran-Ferrer, Marti;

(...)

Capella-Gutierrez, Salvador; Li Gelp, Josep; Lopez-Bigas, Niiria; Garcia-Roves, Pablo M; Martin-Subero, Jose, I.

Referència: Nature Medicine 2022.
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics

Autors:
Nadeu, Ferran; Royo, Romina; Clot, Guillem; Duran-Ferrer, Marti; Navarro, Alba;

(...)

Jares, Pedro; Puente, Xose S; Martin-Subero, Jose I; Delgado, Julio; Campo, Elias.

Referència: Blood 2021.
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes

Autors:
Nadeu, Ferran; Martin-Garcia, David; Clot, Guillem; Diaz-Navarro, Ander; Duran-Ferrer, Marti;

(...)

Kuppers, Ralf; Martin-Subero, Jose, I; Puente, Xose S; Bea, Silvia; Campo, Elias.

Referència: Blood 2020.
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms

Autors:
Nadeu, Ferran; Mas-de-les-Valls, Rut; Navarro, Alba; Royo, Romina; Martin, Silvia;

(...)

Puente, Xose S; Campbell, Peter J; Bea, Silvia; Maura, Francesco; Campo, Elias.

Referència: Nature Communications 2020.
Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia

Autors:
Nadeu, Ferran; Diaz-Navarro, Ander; Delgado, Julio; Puente, Xose S; Campo, Elias;

Referència: Annual Review Of Pathology-Mechanisms Of Disease 2020.
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

Autors:
Nadeu, F; Clot, G; Delgado, J; Martin-Garcia, D; Baumann, T;

(...)

Puente, X S; Lopez-Otin, C; Lopez-Guillermo, A; Enjuanes, A; Campo, E.

Referència: Leukemia 2018.
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

Autors:
Nadeu, Ferran; Delgado, Julio; Royo, Cristina; Baumann, Tycho; Stankovic, Tatjana;

(...)

Colado, Enrique; Puente, Xose S; Lopez-Otin, Carlos; Enjuanes, Anna; Campo, Elias.

Referència: Blood 2016.

Projectes destacats

Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints

Investigador/a principal: Ferran Nadeu Prat

Finançador: European Hematology Association (EHA)

Codi: EHA Junior Research Grant 2021 (RG-202012-00245)

Durada: 01/01/2022 - 31/12/2024
Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints

Investigador/a principal: Ferran Nadeu Prat

Finançador: Lady Tata Memorial Trust

Codi: International Award for Research in Leukaemia 2021-2022 (LADY_TATA_21_3223)

Durada: 01/10/2021 - 30/09/2022
Tracking the progression and transformation of chronic lymphocytic leukemia

Investigador/a principal: Ferran Nadeu Prat

Finançador: American Association for Cancer Research (AACR)

Codi: American Association for Cancer Research (AACR)-Amgen Fellowship in Clinical/Translational Cancer Research (21-40-11-NADE)

Durada: 01/07/2021 - 30/06/2023

Ferran Nadeu

Grup de recerca

Publicacions destacades

Projectes destacats

Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints

Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints

Tracking the progression and transformation of chronic lymphocytic leukemia

Subscriu-te a la Newsletter del Clínic